Male Fertility Test: What a Semen Analysis Measures and What the Numbers Mean

The cup sits on the bathroom counter with a label already printed with his name, and the instructions say to collect the entire sample. That small, awkward moment is where most male fertility evaluations begin, and lately far more men are getting there. Searches for a male fertility test have climbed alongside two currents: a wave of social-media posts warning that sperm counts are collapsing, and a crowd of mail-order kits promising a verdict from a phone camera.

Both currents trace back to real science. As of this writing in 2025, the most-cited evidence is a 2022 meta-analysis reporting that average sperm concentration fell by roughly half between 1973 and 2018, and a 2021 rewrite of the World Health Organization laboratory manual that changed how labs describe a “normal” result. Neither finding means a number on a report card decides whether a man will become a father.

What follows is a plain-language tour of what the test measures, what the numbers can and cannot tell you, and where the headlines outrun the data.

What changed recently in male fertility testing

Three developments explain why this topic is suddenly everywhere. The first is a laboratory rulebook. In July 2021 the World Health Organization published the sixth edition of its manual for examining human semen, the document nearly every andrology lab follows. Andrology is the branch of medicine dealing with male reproductive health. The new edition kept the familiar reference numbers roughly where they were, but it leaned harder on a point earlier editions made quietly: these values are the fifth percentile of results from men who had recently fathered a child, not a pass mark. A man below a threshold is not automatically infertile, and a man above it is not guaranteed to conceive quickly.

The second development was a paper. In November 2022, researchers pooled 223 studies from 53 countries and reported that mean sperm concentration dropped 51.6 percent between 1973 and 2018, with total sperm count falling 62.3 percent over the same period. Their analysis also suggested the decline accelerated after 2000, to more than 2.6 percent per year. The study appeared in a peer-reviewed journal and is indexed on PubMed, and it became the backbone of countless viral posts about sperm count decline. Its methods have been debated by other scientists, a point worth holding onto for later.

The third shift is technological and commercial. Several home semen-testing devices are now regulated as medical devices and cleared to estimate sperm concentration, or in some cases the concentration of moving sperm, using a smartphone or a small reader. They measure one or two variables. A laboratory semen analysis measures eight or more. That gap between what a kit shows and what a clinician needs is one reason searches for a proper male fertility test have grown alongside kit sales. The Mayo Clinic’s overview of diagnosing male infertility describes the full stepwise workup that a kit cannot replace.

How can a man get tested for fertility?

The usual route runs through a primary care clinician, a urologist, or a fertility clinic, and it starts with a conversation before it starts with a cup. Expect questions about how long the couple has been trying, past pregnancies with any partner, childhood conditions such as undescended testicles, surgeries in the groin area, infections, medications, heat exposure at work, and habits including smoking, alcohol, and cannabis. A physical examination follows, checking testicular size and feeling for a varicocele, which is an enlarged cluster of veins in the scrotum that can warm the testicles and is the most common correctable finding in men with fertility difficulties.

Then comes the semen analysis. A semen analysis is a laboratory test that counts and observes sperm in a freshly produced sample. Most labs ask for two to seven days without ejaculation beforehand, because shorter gaps lower the count and longer gaps raise the share of sluggish or dead sperm. The sample is produced by masturbation into a sterile container, ideally at the lab, since sperm movement is assessed within about an hour of collection. If collecting at home, the sample must be kept close to body temperature and delivered quickly according to the lab’s instructions.

The NHS guidance on infertility diagnosis notes that if the first result is abnormal, the test is generally repeated, often about three months later, because sperm take roughly ten to twelve weeks to mature. Two samples spaced apart paint a far more honest picture than one. Depending on the findings, a clinician may add blood tests for hormones, a scrotal ultrasound, or genetic studies. Fertility testing is a couple’s exercise; roughly one-third of cases involve a male factor alone, one-third a female factor alone, and one-third both or unexplained, so the partner’s evaluation typically proceeds in parallel.

What a semen analysis actually measures

Think of the report as a snapshot of a factory’s output on one particular day. The laboratory first records the physical properties of the fluid, then turns a microscope on the cells swimming in it.

On the fluid side, technicians note volume in milliliters, appearance, liquefaction time, viscosity, and pH. Liquefaction is the process by which the gel-like fresh sample turns watery, which normally happens within 15 to 60 minutes; failure to liquefy can hint at a problem with the prostate’s contribution to the fluid. Viscosity describes how thick the liquid remains after that. A pH reading measures acidity; semen is normally slightly alkaline, and a very acidic, low-volume sample can point toward blocked or absent seminal vesicles, the glands that make most of the fluid.

On the cellular side, the lab estimates sperm concentration, meaning the number of sperm per milliliter, and multiplies it by the volume to get total sperm count per ejaculate. It then classifies movement, called motility, into progressive (swimming forward), non-progressive (moving but going nowhere), and immotile. Vitality testing uses a dye that living sperm exclude, distinguishing dead sperm from alive-but-still ones. Morphology, the assessment of shape, is scored under strict criteria that count only sperm with an oval head, an intact midpiece, and a single straight tail as normal.

Labs also look for round cells, which may be immature sperm or white blood cells. A high white cell count can suggest infection or inflammation. Some laboratories report agglutination, where motile sperm stick to one another, a finding that sometimes prompts testing for antibodies against sperm. MedlinePlus lists these measures in its plain-language description of the test. Not every lab reports every item, and the report’s layout varies, which is exactly why the numbers deserve interpretation by someone who reads them daily.

Semen analysis reference values: what the numbers mean

The table below shows the lower reference limits from the WHO’s sixth-edition manual, with the fifth-edition values for comparison because many labs and older articles still quote them. Each figure represents the fifth percentile among men whose partners conceived within a year, so about one in twenty fertile men falls below any given line. Reading the table as pass or fail misses that point entirely.

Measure	What it describes	WHO 6th edition (2021)	WHO 5th edition (2010)
Semen volume	Fluid per ejaculate	1.4 mL	1.5 mL
Sperm concentration	Sperm per milliliter	16 million/mL	15 million/mL
Total sperm number	Sperm per ejaculate	39 million	39 million
Total motility	Any movement	42%	40%
Progressive motility	Forward movement	30%	32%
Vitality	Living sperm	54%	58%
Normal morphology	Ideal shape (strict criteria)	4%	4%

Several patterns stand out. The morphology threshold of 4 percent surprises almost everyone; it means 96 out of 100 sperm can look imperfect and the result still sits within the reference range. Total sperm number, not concentration alone, is what many specialists watch most closely, because a modest concentration in a generous volume can deliver more sperm than a high concentration in a tiny one.

The small differences between editions are not evidence that men changed between 2010 and 2021. They reflect a larger and more geographically diverse pool of fertile men in the newer dataset. The Cleveland Clinic’s semen analysis guide makes the same point in plainer words: the numbers are a starting point for discussion, not a diagnosis, and a clinician weighs them against the physical exam, medical history, and the partner’s evaluation.

Sperm count explained: concentration versus total number

The phrase “sperm count” gets used loosely, and the looseness causes confusion. On a lab report it appears twice, in two different forms. Concentration is the density figure, sperm per milliliter. Total sperm number is that density multiplied by the volume of the whole sample. Two men can share a concentration of 20 million per milliliter and yet deliver very different totals: 30 million in a 1.5-milliliter sample versus 80 million in a 4-milliliter one.

Laboratories describe results below the reference limits with specific terms. Oligozoospermia means a low sperm concentration. Azoospermia means no sperm are found in the ejaculate at all, a finding present in roughly 1 percent of men and about 10 to 15 percent of men evaluated for infertility. Azoospermia divides into two broad types. Obstructive azoospermia means sperm are being made but a blockage, such as a prior vasectomy, an absent vas deferens, or scarring from infection, prevents them from reaching the semen. Non-obstructive azoospermia means the testicles are producing few or no sperm, often for hormonal or genetic reasons. The distinction matters enormously for what happens next, and it cannot be made from the semen sample alone.

What does a low number actually mean for conception? Observational studies consistently show that the chance of pregnancy per month rises with sperm count up to a point and then plateaus; above roughly 40 million total sperm, more does not clearly translate into faster conception. Below the reference limits, pregnancy becomes statistically less likely per cycle but remains entirely possible for many couples. A count is a probability signal, not a verdict.

Counts also swing. The same man can produce samples that differ by 30 percent or more from week to week depending on abstinence interval, recent fever, stress, and simple biological noise. Any single low count that has not been repeated is a prompt for a second test, not for alarm.

Sperm motility: is 38% sperm motility good?

Motility describes what share of sperm are moving, and it is the number that generates the most anxious searches, including that very specific question. A total motility of 38 percent sits just under the WHO sixth-edition reference limit of 42 percent and the older fifth-edition limit of 40 percent. Statistically, that places the result near the bottom of the range seen in recently fertile men, but still within the spread of men who conceived. It is not a fertility cutoff, and it is not something a man should interpret alone.

Two details matter more than the headline percentage. The first is progressive motility, the fraction of sperm swimming actively forward rather than twitching in place. Progressive movement is what carries a sperm through cervical mucus and up the reproductive tract, and specialists weigh it more heavily than total motility. The reference limit is 30 percent. A man with 38 percent total motility of which 33 percent is progressive is in a different position from one whose 38 percent is mostly non-progressive.

The second detail is the absolute count of moving sperm, sometimes called total motile sperm count. Multiply total sperm number by the motile fraction and you get the number of swimmers in the ejaculate. A sample with 120 million sperm and 38 percent motility contains about 46 million moving sperm; a sample with 20 million sperm and 60 percent motility contains 12 million. The first man’s “lower” percentage delivers nearly four times as many motile sperm. Many fertility clinics use this combined figure when discussing options.

Motility is also the most fragile measurement on the report. Sperm slow down when a sample cools, when it sits too long before analysis, or after a recent fever. Lubricants and even saliva can impair movement. For all these reasons, the standard response to a borderline motility result is straightforward: repeat the test under good collection conditions, and let the treating clinician interpret both results together.

Sperm morphology: why a 4% "normal" result is not a typo

Morphology, the shape assessment, produces the most alarming-looking number on the page and the one most often misread. Under the strict criteria labs now use, technicians examine at least 200 sperm and count as normal only those with a smooth oval head of specific dimensions, a well-defined acrosome (the cap that helps the sperm penetrate the egg), a slender midpiece, and a single uncoiled tail. Anything off is classified as abnormal: heads too large or small, doubled heads, bent necks, coiled tails, or cytoplasmic droplets left over from immature development.

By that standard, most sperm from most men fail. The WHO reference limit of 4 percent normal forms means that a man with 5 percent ideal shapes has a result within the range of recently fertile men. A result of 2 percent, called teratozoospermia, is below the limit, but studies of natural conception show that isolated low morphology, with normal count and motility, has a weaker association with pregnancy rates than either of the other two measures. Morphology carries more weight in the laboratory context of assisted reproduction, where embryologists select individual sperm, than it does in predicting conception at home.

The measurement is also notably subjective. Two trained technicians scoring the same slide can disagree by several percentage points, and inter-laboratory variation is well documented. That is not carelessness; it is the nature of judging shapes by eye against a strict template. Computer-assisted systems exist but have not replaced human scoring in most labs.

A morphology result therefore deserves the calmest reading of any number on the report. When it is low in isolation, most clinicians will note it, repeat the analysis, and focus attention on the physical exam, count, and motility. When it is low alongside those other measures, it adds to a pattern that warrants a closer look. Either way, the interpretation belongs to the clinician holding the whole picture, not to a search engine at midnight.

Volume, pH, liquefaction and white cells: the numbers people skip

Below the headline sperm figures sit a cluster of measurements that most men ignore and most specialists scan first. They describe the fluid rather than the cells, and they can point toward the origin of a problem.

Semen volume is the clearest example. About two-thirds of the fluid comes from the seminal vesicles, roughly a quarter from the prostate, and only a small fraction from the testicles and their ducts. A volume below the 1.4-milliliter reference, especially with a low pH and no sperm, raises the possibility that the seminal vesicles are absent or blocked, a pattern seen with congenital absence of the vas deferens. That condition is associated with variants in the gene responsible for cystic fibrosis, which is why an unexpectedly low-volume, acidic, sperm-free sample can lead to a genetics conversation the man never anticipated. Low volume can also simply reflect spillage during collection or a short abstinence period, which is why the lab asks whether the entire sample made it into the cup.

Liquefaction, the transition from gel to liquid, normally completes within an hour. Delayed liquefaction and high viscosity can trap sperm and artificially lower motility readings. White blood cells above one million per milliliter, a finding called leukocytospermia, may signal infection or inflammation in the prostate or urethra, though many men with elevated white cells have no identifiable infection. When present, a clinician may order a semen culture or urine test.

Some laboratories report antisperm antibodies when agglutination is seen, but the clinical relevance of a positive antibody test remains debated, and routine antibody testing is not recommended by most guidelines. Fructose testing, which checks for a sugar produced by the seminal vesicles, is occasionally used when azoospermia and low volume coexist. None of these items decides fertility on its own. They function as clues, and a good clinician reads them the way a mechanic listens to an engine before opening the hood.

Why one male fertility test result is never the final word

Sperm are made continuously, and the batch in any given sample began developing about ten to twelve weeks earlier. That timeline explains a great deal about why results wobble. A fever in January can show up as a poor count in March. A course of certain medications, a period of heavy alcohol use, or a stretch of long hot baths can each leave a temporary fingerprint that fades by the next season.

Beyond those biological rhythms, plain measurement variability is large. Studies that asked the same men to provide multiple samples found within-person differences in concentration of 30 percent or more, with motility and morphology equally unstable. The abstinence interval alone shifts results predictably: two days versus five days can mean a meaningfully different concentration from the same man. Collection conditions add another layer. A sample that cooled in a car for 40 minutes, or was produced with a lubricant, will underreport motility no matter how healthy the sperm.

Guideline bodies therefore treat a single abnormal result as a reason to test again, not as a diagnosis. The Mayo Clinic’s diagnostic overview describes repeating the analysis, and the NHS advises that abnormal first results are generally rechecked, with an interval of roughly three months commonly used so that an entirely new cohort of sperm is being assessed. Two concordant results carry real weight. Two discordant results are themselves informative, suggesting something transient affected the first.

There is one exception to the wait-and-repeat approach. When no sperm at all are found, labs typically centrifuge the sample and re-examine the sediment, and clinicians usually move more quickly to hormone testing and a physical exam rather than waiting months, because the distinction between blocked and non-producing causes shapes the entire path forward. Even here, the second sample is still collected; the difference is that other tests run alongside it rather than after it.

What are signs of poor sperm health? Usually, there are none

The honest answer disappoints people looking for a checklist. In most men with low counts or poor motility, semen looks, smells, and behaves entirely normally. Ejaculate volume feels ordinary, sex drive is unchanged, and nothing about daily life hints at the microscopic picture. The main sign of a male fertility problem is the absence of pregnancy after a year of regular unprotected intercourse, or after six months if the female partner is 35 or older. That is why the male fertility test exists: because the body rarely announces the problem.

Certain findings do correlate with reduced sperm production or delivery, and a clinician will ask about them. A history of undescended testicles in childhood, even if surgically corrected, is associated with lower counts in adulthood. Prior groin or scrotal surgery, testicular injury, mumps after puberty, or treatment for cancer with chemotherapy or radiation all raise the likelihood of impaired production. A visible or palpable swelling above the testicle, often described as feeling like a bag of worms and more noticeable when standing, may be a varicocele.

Hormonal causes sometimes do produce symptoms. Reduced facial or body hair, loss of muscle mass, breast tissue enlargement, low libido, or difficulty with erections can accompany low testosterone or pituitary problems, and these warrant evaluation in their own right. Pain, swelling, or a lump in a testicle deserves prompt attention regardless of fertility plans. Very small testicular volume on examination is one of the more reliable physical signs of reduced sperm production, but it is something a clinician measures rather than something most men notice.

The takeaway is not reassurance or alarm but calibration. Feeling healthy tells you little about sperm health, and feeling worried tells you nothing about the count. Only the test does, and even then only in the context of a full evaluation of both partners.

At-home male fertility tests versus a laboratory semen analysis

Mail-order kits have turned a clinical test into a consumer product, and their appeal is understandable. Privacy, no appointment, a result on a phone screen within minutes. Some of these devices are regulated as medical devices and have been cleared to estimate sperm concentration, and a few also estimate the concentration of moving sperm. Within those narrow claims, published validation studies generally show reasonable agreement with laboratory counts at the threshold they are designed to flag.

The limitations are structural rather than a matter of quality. A kit that reports concentration cannot tell a man his total sperm number without an accurate volume measurement, and few home users measure volume the way a lab does. Kits do not assess morphology, vitality, pH, liquefaction, white cells, or the progressive-versus-non-progressive split in motility that clinicians care about. They cannot detect the low-volume, acidic pattern that signals a ductal problem, and they cannot distinguish a blocked system from a non-producing one. A reassuring home result with a normal concentration is somewhat informative. A worrying one is a prompt to get a laboratory test, and a normal one does not rule out issues the kit was never built to find.

Timing and technique create another gap. Laboratory analysis occurs under controlled temperature within a set window after collection. Home conditions vary, and cooling or delay depresses motility readings, which can make a healthy sample look poor or, with some kit designs, make a poor one look acceptable.

The fairest way to describe the two options is as different tools. A home kit is a screening signal, a single dial on the dashboard. A laboratory semen analysis is the full instrument panel, and it comes attached to a clinician who can order the hormone, genetic, and imaging tests that follow when a result is abnormal. Men who prefer to start at home are not doing anything wrong, provided the kit is understood as a first step rather than a substitute for the evaluation the Mayo Clinic and NHS describe.

Beyond semen: hormone tests, genetics and imaging

When a repeated semen analysis is abnormal, or when the physical examination raises questions, the male fertility test expands beyond the microscope. Blood tests come first, usually drawn in the morning when hormone levels are most stable. Follicle-stimulating hormone, or FSH, is a pituitary hormone that drives sperm production; a high level with a low count suggests the testicles themselves are struggling, while a low or normal level with very few sperm points toward a blockage or a signaling problem higher up. Testosterone is the main male sex hormone, and a low level may indicate a testicular or pituitary cause. Luteinizing hormone and prolactin are sometimes added to locate the source of a hormonal disturbance.

One fact from this area surprises many men: testosterone taken as a medicine, including for low-energy or gym-related reasons, suppresses the pituitary signals that drive sperm production and can reduce counts dramatically, sometimes to zero. Any man who has used testosterone or related anabolic products should tell the evaluating clinician; decisions about what to do next belong with that clinician, not with a blog.

Genetic testing enters the picture when sperm concentration is very low or absent. A karyotype looks at the overall chromosome set and can identify conditions such as Klinefelter syndrome, in which a man has an extra X chromosome. Y-chromosome microdeletion testing looks for missing segments of the Y chromosome in regions essential for sperm production. Cystic fibrosis gene testing is considered when the vas deferens is absent. These results carry implications for children conceived through assisted reproduction, so genetic counseling accompanies them.

Imaging rounds things out. Scrotal ultrasound assesses testicular size, structure, and the presence of a varicocele, and can detect masses that need evaluation regardless of fertility. Transrectal ultrasound is occasionally used when a blockage near the prostate is suspected. In select cases of azoospermia, a testicular biopsy determines whether sperm are being produced at all. Each test answers a specific question, and the sequence is chosen by the clinician based on the pattern the earlier results revealed.

What the evidence actually says about sperm count decline and sperm health

Grading the evidence matters here because the claims travel faster than the caveats.

The decline itself rests on observational data pooled by meta-regression, the statistical technique of combining many studies and modeling trends over time. The 2022 analysis drew on 223 studies spanning 45 years and found a roughly 50 percent fall in mean concentration in men not selected for fertility problems. That is a large body of data, and the direction of the finding has been reproduced across several independent reviews. It remains observational: studies from different decades used different lab methods, recruited different populations, and applied different abstinence rules. Critics have argued that early studies over-represented certain regions and that counting methods changed. The finding is best described as strongly suggested but not proven to the standard of controlled experiments, which in this case are impossible to run. Whether the decline has affected the chance of natural conception at a population level is even less certain; the reference limits from fertile men have barely moved between manual editions.

Lifestyle factors sit on firmer but still mostly observational ground. Smoking is consistently associated with lower counts and motility across large cohorts. Obesity is linked with reduced concentration and altered hormones, with some small trials suggesting weight loss improves parameters. Heat exposure, including frequent hot tubs and saunas, reduces motility in the short term in controlled studies, with recovery after exposure stops. Heavy alcohol intake and cannabis use show associations with poorer parameters, though study quality varies.

Supplements are where the evidence thins sharply. Antioxidant preparations have been tested in randomized trials, but a large, well-designed 2020 trial found no improvement in live birth rates despite earlier smaller studies suggesting benefit on lab parameters. The NIH Office of Dietary Supplements notes that evidence for most fertility supplements in men is limited or inconsistent. Expert opinion supports healthy habits; randomized evidence that any pill raises the odds of a baby is weak. That hierarchy, from observational association to randomized trial to hard outcome, is the lens to apply to every sperm health claim you encounter.

Common myths about sperm health, corrected

The viral version of this subject is a mix of half-truths, and a few deserve direct correction.

The first myth holds that a single low result means infertility. It does not. Results below reference limits describe reduced probability, not impossibility, and roughly one in twenty fertile men falls below any given threshold. A second sample and a full evaluation are the standard response.

The second myth is that laptops, phones, and tight underwear are proven causes of infertility. The evidence is more modest. Scrotal heat does impair sperm production in controlled studies, and briefs raise scrotal temperature slightly compared with looser styles, but the effect on actual conception rates in ordinary life is unclear and small at most. Phone radiation studies are inconsistent and largely low quality. Reasonable habits are sensible; panic is not supported.

The third myth says that abstaining for weeks before trying to conceive saves up a better sample. Longer abstinence raises total count but increases the share of immotile and damaged sperm, which is why labs cap the recommended interval at about seven days and many clinicians suggest intercourse every one to two days around ovulation.

The fourth myth claims morphology of 4 percent means 96 percent of sperm are defective in a way that dooms conception. Strict criteria are deliberately demanding, and a low isolated morphology score has a weaker link to natural pregnancy than count or motility.

The fifth myth is that sperm health is purely a young man’s concern. Sperm parameters and DNA integrity decline gradually with age, and paternal age above about 40 is associated in observational studies with modestly longer time to conception and small increases in certain risks, though the effect is far gentler than the age curve for eggs.

The sixth, and most commercially convenient, is that a supplement stack reliably fixes numbers. Randomized trials have not shown improved live birth rates. Anyone considering a supplement should discuss it with the treating clinician rather than trust a testimonial.

When to see a doctor about male fertility

The clearest trigger is time. Couples who have not conceived after twelve months of regular unprotected intercourse should both be evaluated, and after six months if the female partner is 35 or older. Waiting longer rarely helps and can narrow options, particularly given how strongly the partner’s age shapes outcomes.

Some situations justify seeking evaluation without waiting for that clock to run. A known history of undescended testicles, testicular injury or surgery, chemotherapy or radiation, or prior groin operations places a man at higher risk of reduced sperm production. Difficulty with erections or ejaculation, very low semen volume, or a noticeable change in sex drive warrant a conversation regardless of fertility plans. Men who have used testosterone or anabolic steroids and now hope to conceive should raise this early, since these agents suppress sperm production and the path forward must be managed by the prescribing clinician; no one should stop or change a prescribed medicine on their own.

Certain findings are red flags that need prompt medical attention rather than a routine appointment. A lump, hardness, or swelling in a testicle, with or without pain, requires evaluation to rule out a tumor, and testicular cancer is most common in men between 15 and 45. Sudden severe testicular pain is an emergency. Blood in the semen, pain with ejaculation, fever with scrotal swelling, or discharge from the penis can indicate infection that needs treatment. A home kit result showing zero or extremely low concentration should be followed by laboratory testing and a clinical exam rather than repeated home tests.

Expect the visit to include a history, an examination, and an order for one or two laboratory semen analyses, followed by hormone tests, imaging, or genetic studies only if the pattern calls for them. Every decision about what those results mean, whether to treat, and what treatment to consider rests with the treating clinician who can see the full picture, including the partner’s evaluation. This article can explain the numbers. It cannot interpret yours.

Frequently asked questions

How can a man get tested for fertility?

The standard route is a visit to a primary care clinician, urologist, or fertility clinic, where a medical history and physical examination are followed by a laboratory semen analysis. The lab asks for two to seven days without ejaculation before providing a sample by masturbation into a sterile container. An abnormal result is usually repeated about three months later, and hormone blood tests, ultrasound, or genetic testing are added only when the pattern of results calls for them.

What are signs of poor sperm?

Most men with low sperm count or poor motility have no symptoms at all; semen looks and behaves normally. The main sign is not conceiving after twelve months of regular unprotected intercourse. Physical findings that raise the likelihood of a problem include small testicles, a varicocele, a history of undescended testicles, or prior groin surgery. Symptoms of low testosterone, such as reduced body hair, low libido, or breast enlargement, can accompany hormonal causes and deserve evaluation.

How to check if a male is fertile?

There is no single test that confirms fertility, but a laboratory semen analysis is the closest available tool. It measures volume, sperm concentration, total count, motility, morphology, and vitality, and compares them with WHO reference ranges from fertile men. Results within those ranges make natural conception statistically more likely but do not guarantee it, and results below them lower the odds without ruling it out. A clinician interprets the numbers alongside the physical exam and the partner’s evaluation.

Is 38% sperm motility good?

A total motility of 38 percent falls just below the WHO sixth-edition reference limit of 42 percent, placing it near the lower end of the range seen in recently fertile men rather than outside the realm of normal conception. More informative are the progressive motility fraction, with a reference limit of 30 percent, and the total number of moving sperm in the sample. Because motility is easily lowered by cooling or delay, clinicians typically repeat the test before drawing conclusions.

Is sperm count decline real, and should I worry about it?

A 2022 meta-analysis of 223 studies from 53 countries found that average sperm concentration fell about 51.6 percent between 1973 and 2018, and several other reviews point in the same direction. The evidence is observational and has been criticized for differences in laboratory methods and populations across decades, so it is best described as strongly suggested rather than proven. Population averages say little about any individual; a personal semen analysis does.

How long should I abstain before a semen analysis?

Most laboratories ask for two to seven days without ejaculation before the sample. Shorter intervals lower sperm concentration and total count, while longer intervals increase the proportion of immotile and damaged sperm, so both extremes can distort results. Following the specific instructions from the lab you use matters more than any general rule, and keeping the interval similar between a first and repeat test makes the two results easier to compare.

Can an at-home male fertility test replace a lab semen analysis?

No. Home kits regulated as medical devices can estimate sperm concentration, and some estimate the concentration of moving sperm, but they do not measure volume accurately, morphology, vitality, pH, liquefaction, or white blood cells. A normal home result is a modest reassurance; an abnormal one should prompt a laboratory analysis and clinical examination. Laboratory testing also connects a man to a clinician who can order the hormone, imaging, and genetic tests that follow abnormal results.

Does a man's age affect sperm health?

Yes, though more gently than age affects eggs. Observational studies show that semen volume, motility, and morphology decline gradually from around age 40, and sperm DNA fragmentation, meaning breaks in the genetic material, increases with age. Older paternal age is associated with modestly longer time to conception and small increases in certain risks for offspring. Many men father children well into later life, and age is one factor among many that a clinician weighs.

What does 4% normal morphology mean on my report?

It means 4 out of every 100 sperm examined met strict criteria for ideal shape, which is exactly the WHO reference limit and within the range seen in fertile men. Strict morphology scoring is deliberately demanding, classifying most sperm from most men as abnormal. Isolated low morphology with normal count and motility has a weaker link to natural conception than the other measures, and the score varies between technicians, so clinicians interpret it cautiously and in context.

What is azoospermia and what happens next?

Azoospermia means no sperm are found in the ejaculate, a finding in roughly 1 percent of men and 10 to 15 percent of those evaluated for infertility. The lab typically re-examines the sample after centrifuging it. A clinician then distinguishes obstructive causes, where sperm are produced but blocked, from non-obstructive causes, where production is impaired, using hormone tests, examination, and sometimes genetic testing or ultrasound. Which type it is determines the options, and that assessment belongs to the treating clinician.

References

• MedlinePlus: Semen Analysis
• NHS: Infertility: Diagnosis
• Cleveland Clinic: Semen Analysis
• WHO: Laboratory manual for the examination and processing of human semen, sixth edition

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.